New app aims to simplify breast surgery journey
NCT ID NCT05290402
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a mobile app called JEEVA designed to help breast surgery patients before and after their operation. 60 patients used the app to see if it was easy to use and helpful. The goal was to learn how accessible the app is, not to measure health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- JEEVA digital health navigator app
- What this could lead to
- If successful, this app could make it easier for breast surgery patients to get information and support before and after their operation.
- What could go wrong
- This was a small, early study focused on usability, not on health outcomes. The app may not improve recovery or be useful for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
60 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Breast Surgery Patients
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Subjects eligible for this study include breast surgical patients 18 years of age and older evaluated at the Texas Medical Center campus in the Nellie B Connally breast center or in the Houston Area Locations (HALs). This includes patients undergoing excisional biopsy, segmental mastectomy, total mastectomy, skin-sparing mastectomy, nipple-sparing mastectomy, sentinel lymphadenectomy, targeted axillary lymphadenectomy, axillary lymphadenectomy, and axillary reverse mapping. Exclusion Criteria: Patients who do not have a smartphone), which utilizes iOS or Android operating systems, Patients who have visual impairment or blindness, which precludes effective utilization of an app, will be excluded. Patients whose surgical planning is discussed by telephone outside of an in-person pre-operative visit, will be excluded from the study. Patients who have cognitive impairment will be exclude
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can light and sound replace X-Rays? a new imaging method aims to see inside without radiation
- Could a short course of physiotherapy improve posture and ease pain after breast reduction?
- Bionic breast implant aims to bring back sensation after mastectomy
- New 3D ultrasound aims to improve breast cancer diagnosis without radiation
- New combo aims to wipe out hidden breast cancer cells after standard treatment
- New pain drug could ease recovery after breast surgery